î
îŒ
î
NLS Pharmaceutics AG
NLSPWî¹
詳现ãã£ãŒãã衚瀺
0.018USD
0.0000.00%
çµå€Â 02/06, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
0.00æ䟡ç·é¡
--çŽè¿12ã¶æPER
î
Intraday
1m
30m
1h
D
W
M
D
æ¬æ¥
0.00%
5æ¥é
0.00%
1ã¶æ
0.00%
6ã¶æ
+16.99%
幎åæ¥
0.00%
1幎é
0.00%
詳现ãã£ãŒãã衚瀺
TradingKey æ ªåŒã¹ã³ã¢
ããŒã¿ãäžååãªãããæ ªåŒã¹ã³ã¢ã¯å©çšã§ããŸããã
NLS Pharmaceutics AG ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
NLS Pharmaceutics AGã®äŒæ¥æ å ±î
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.
äŒæ¥ã³ãŒãNLSPW
äŒæ¥åNLS Pharmaceutics AG
æé«çµå¶è²¬ä»»è
ãCEOãMr. Alexander Zwyer
ãŠã§ããµã€ãhttps://nlspharma.com/
人æ°éæ
278.120
+2.210Â (+0.80%)
185.410
+13.530Â (+7.87%)
67906.820
-2063.310Â (-2.95%)
282.580
+22.390Â (+8.61%)
2002.980
-48.750Â (-2.38%)
411.110
+13.900Â (+3.50%)
4952.980
+142.360Â (+2.96%)
63.303
+0.206Â (+0.33%)
1.182
+0.004Â (+0.35%)
157.098
+0.057Â (+0.04%)
